What Privacy Analytics does

Privacy Analytics is an Ottawa-based data privacy technology and services company founded in 2007 that specializes in risk-based statistical de-identification of sensitive personal data. Its core offering combines proprietary software — the Privacy Analytics Platform and the Eclipse family of modules (Eclipse Risk, Eclipse Trials, HIPAA Expert Determination, and Mirage) — with expert advisory and managed Privacy-as-a-Service engagements that deliver auditable Expert Determinations aligned with HIPAA, GDPR, CCPA, EU Clinical Trials Regulation, Health Canada PRCI, and EMA Policy 0070. The technical foundation rests on the Five Safes framework (Safe Projects, Safe People, Safe Settings, Safe Data, Safe Outputs), reinforced by 25+ patents and a research team with hundreds of peer-reviewed publications across statistics, anonymization, and clinical trial transparency.

Privacy Analytics serves more than 200 enterprise and government customers across healthcare, life sciences, transportation/mobility, and other regulated industries, with named engagements including Fresenius Medical Care (Apollo Dial DB covering approximately 540,000 dialysis patients across 40+ countries), Epic’s Cosmos research network (1,200+ hospitals, 30,000+ clinics), Geotab (3 million+ connected vehicles, 55 billion data points per day), Novartis, Uber, Comcast, Nuance Communications, Modern Health, and Zephyr AI. Revenue mechanics blend subscription licensing of Eclipse modules, project-based professional services for Expert Determination and Clinical Trial Transparency, and managed Privacy-as-a-Service contracts, sold predominantly through direct enterprise sales with a self-service / product-led-growth overlay for Eclipse. The firm operates in close association with IQVIA based on repeated team-page references to “IQVIA’s Privacy Analytics,” and lists a Director for EMEA alongside a US/Canada commercial footprint, signaling an executed go-to-market starting to push into the EU and UK.

The business is anchored by a senior leadership team with deep domain expertise: founder Dr. Khaled El Emam (a published author in health data anonymization), Head of Privacy Analytics Jordan Collins (and separately Sarah Lyons), Head of Product and Methodology Grant Middleton, Director of Clinical Trial Transparency Niamh McGuinness, Director EMEA Jonathan Green, Compliance Officer Pierre Chetelat, AI Practice Lead Luk Arbuckle, and an international team of data scientists, ML engineers, and clinical trial transparency specialists. Privately held, with only ~$4.875M cumulative disclosed equity funding across a 2012 seed and a 2014 round, the firm has been funded primarily through customer revenue and its IQVIA affiliation rather than recurring institutional capital.

Name

Privacy Analytics

Legal name

Privacy Analytics Incorporated

Website

https://privacy-analytics.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Privacy Analytics provides statistical de-identification software and expert advisory services that let healthcare, life sciences, and regulated enterprises safely share and analyze sensitive data under HIPAA, GDPR, CCPA, and clinical-trial transparency rules.

Ownership category

akta.pro rank

Product category

Data Privacy and De-identification Software

NAICS

Software Publishers (5132), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182)

SIC

Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

De-identification, Tokenization & Privacy-Preserving Data Platforms (HLACAIAK)

akta.pro secondary industries

Consent, Privacy Management & Patient Identity (CIAM/Consent) (HLACAJAL), AI Privacy Engineering & Data Governance (PII, consent, retention) (HDAAAKAB), Privacy-Preserving Data (De-identification, Anonymization, PII Redaction) (HDAAALAG), Privacy Management (Consent, DSAR, RoPA) (HDADAFAH)

Keywords

• Data anonymization software
• Healthcare privacy compliance
• De-identification services
• HIPAA expert determination
• Clinical trial transparency

Headquarters

HQ city

Ottawa

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Software Platform Subscriptions: Customers license the Privacy Analytics Platform and Eclipse software modules (e.g., HIPAA Expert Determination, Eclipse Trials) on a subscription basis. The self-service model allows organizations to perform de-identification independently, with scalability across multiple data projects without per-instance consulting fees.
2. Professional Services and Advisory: Expert consulting and advisory engagements including Privacy Consulting and Advisory, Privacy-as-a-Service offerings, and Training. Services are delivered by a team of more than 100 privacy experts and include assessments, anonymization-as-a-service, expert determinations, and regulatory compliance evaluations.
3. Clinical Trial Transparency Services: Specialized services for clinical document anonymization and redaction supporting regulatory submissions under EU Clinical Trials Regulation, Health Canada PRCI, EMA Policy 0070, and other transparency requirements. Offered as service engagements or via Mirage software licenses.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

Core offering

Privacy Analytics provides data anonymization software and expert privacy services that help healthcare, life sciences, and regulated enterprises de-identify personal data while maintaining compliance with HIPAA, GDPR, CCPA, and other privacy regulations. The company sells the Eclipse software platform with modules for risk assessment and clinical trials, plus the Mirage NLP-powered document anonymization tool, alongside Privacy-as-a-Service and expert consulting engagements delivered by 100+ privacy specialists.

Product overview

Privacy Analytics offers a platform-plus-modules architecture centered on the Privacy Analytics Platform and Eclipse Software product family. The core Privacy Analytics Platform provides the foundational technology for safe data deployment, while Eclipse Software serves as the primary automated commercial software with specialized modules including Eclipse Risk (re-identification risk assessment), Eclipse Trials (clinical trial data anonymization), and Mirage Software (NLP-powered document anonymization). The company supplements its software portfolio with managed Privacy-as-a-Service offerings covering DICOM anonymization, HIPAA expert determination, unstructured text anonymization, and global re-identification risk determination. Expert advisory and training services round out the offering, enabling organizations to achieve compliance with GDPR, HIPAA, CCPA, and other global privacy regulations while maximizing data utility.

Differentiator

Problem solved

Functional benefit

Brands

• Privacy Analytics Platform: Commercial software platform for achieving safe data at scale with automated de-identification capabilities
• Eclipse Software
• Eclipse Risk
• Eclipse Trials
• Mirage Software

Products and services

• Privacy Analytics Platform Commercial software platform providing automated capabilities to assess re-identification risk and perform anonymization on sensitive datasets at scale, enabling organizations to achieve safe data while preserving data utility.
• Eclipse Software Automated commercial software for de-identification and risk-based anonymization of datasets, including HIPAA Expert Determination, risk assessment, and clinical trial data processing capabilities for enterprise and government customers.
• Mirage Software NLP-powered clinical trial document anonymization software that delivers high-speed redaction or statistical anonymization for regulatory submissions under EU CTR, Health Canada PRCI, and EMA Policy 0070.
• Privacy Consulting and Advisory Expert advisory services including AI Governance Design and Engineering Services, GDPR Readiness Assessment, and Video Anonymization Evaluation, delivered by a team of 100+ privacy specialists to help organizations design privacy programs and achieve regulatory compliance.
• Privacy-as-a-Service Managed anonymization services including DICOM Anonymization, Global Re-identification Risk Determination, HIPAA Expert Determination and De-identification, Platform Re-identification Risk Determination, and Unstructured Text Anonymization delivered by expert teams.
• Training Training programs including intensive multi-day training on de-identification methodology and Eclipse software usage, with workshops tailored to specific client use cases across healthcare, life sciences, and regulated industries.

Quantifiable outcome

• 25x faster data insights: Fresenius Medical Care analysts now receive global data in less than a week vs. approximately 6 months previously
• +3 more outcomes

Named customers16 records

Segments4 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Partnerships

Three partnerships are on record, tiered minor and core.

• GeotabminorStrategic or Co-development Partner · 1 January 2020Privacy Analytics was engaged by Geotab to independently validate its data anonymization and privacy protection methods before releasing aggregated transportation datasets through its Ignition Platform for public research use. Privacy Analytics conducted a rigorous review including a motivated intruder test, confirming that Geotab's privacy strategies met industry standards and international regulations.
• VivlicoreStrategic or Co-development Partner · 10 October 2018Privacy Analytics partnered with Vivli, a clinical trials data sharing platform, to enable safe sharing of clinical trial data. Dr. Rebecca Li (Vivli Executive Director) and Dr. Khaled El Emam (Privacy Analytics Founder) discussed the partnership's significance for the global health research community, enabling researchers to access anonymized clinical trial data through Vivli's platform.
• Epic (Cosmos)coreStrategic or Co-development PartnerPrivacy Analytics serves as the third-party expert evaluator for Cosmos, one of the world's largest healthcare data collaborations managed by Epic. Privacy Analytics evaluates the Cosmos data environment, conducts expert determination on re-identification risk, and makes recommendations for data transformations. Cosmos supports over 1,200 hospitals and 30,000 clinics, and Privacy Analytics' validation enables Epic's community to conduct deep, line-level statistical research with confidence.

Scale indicators11 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Datavant: Specializes in healthcare data de-identification and linkage for clinical research and real-world evidence, directly comparable to Privacy Analytics' PHI/PII de-identification and tokenization capabilities serving similar pharma, provider, and EHR ecosystem customers.
• HealthVerity: Provides a privacy-protected data linkage and de-identification platform for healthcare and life sciences, sharing the same customer base (pharma, providers, payers) and similar risk-based anonymization and HIPAA/GDPR compliance value proposition.
• MDClone: Offers synthetic data generation and analytics for healthcare, a closely adjacent technology addressing the same underlying need — making patient-level data safely usable for research and AI — sold to similar enterprise hospital and life sciences customers.

Emerging players

• Immuta: Provides an enterprise data privacy and access governance platform with de-identification and policy enforcement capabilities, overlapping on the privacy-preserving data tooling category but serving a broader, less healthcare-vertical mix.
• Privitar (Informatica): Privitar built a privacy-preserving data platform with tokenization and de-identification; now part of Informatica, it competes on similar privacy engineering use cases including clinical and financial data anonymization.
• BigID: Data intelligence and privacy platform providing data discovery, classification, and de-identification of sensitive data (including PHI) across enterprise data estates, with overlap on healthcare de-identification tooling and listed as comparable by Privacy Analytics itself.
• Securiti: Provides AI-powered data privacy and security posture management with sensitive data discovery, consent, and DSAR automation, overlapping on privacy management for healthcare and AI/ML data use cases.
• Protenus: Healthcare-focused privacy monitoring and compliance analytics platform using AI to detect PHI access patterns, addressing adjacent healthcare data protection use cases for similar hospital and health system customers.
• TripleBlind: Privacy-preserving data collaboration platform using de-identification and privacy-enhancing computation techniques for healthcare and AI use cases, overlapping on the privacy-preserving analytics problem space.

Broad incumbents

• OneTrust: Large-scale privacy management, consent, and data governance platform that includes data discovery and anonymization capabilities, serving the same CCPA/GDPR/HIPAA-driven buyer but as part of a much broader privacy GRC portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks1 record

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCXbMEKhATp8wxbZ0IrZUr2g
• LinkedInlinkedin.com/company/privacy-analytics-inc-
• Xx.com/privacyanalytic
• Facebookfacebook.com/privacyanalytics

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles19 records

Funding overview

Funding rounds2 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Privacy Analytics